Xaluritamig trials for Prostate cancer

All Xaluritamig trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Xaluritamig for Prostate cancer

• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
  NCT07213674 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 151 locations
• Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
  NCT06613100 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 9 locations
• Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
  NCT07140900 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 16 locations
• Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
  NCT07493512 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 11 locations

Common questions

How many trials study Xaluritamig for Prostate cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.